Drug intelligence / Profile preview

hydrocodone polistirex

Development stage
Phase 1
Lead developer
Tris Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

**Hydrocodone polistirex** is an extended-release ion-exchange resin complex of hydrocodone, a semisynthetic opioid agonist, primarily used as a centrally acting antitussive and analgesic in combination products. It binds hydrocodone to a sulfonated styrene-divinylbenzene copolymer matrix, enabling controlled release via the Pennkinetic System, which prolongs suppression of the cough reflex by acting on brainstem respiratory centers. Typically formulated with chlorpheniramine polistirex for relief of cough and upper respiratory symptoms associated with allergies or colds, it exhibits peak plasma concentrations around 3.4 hours post-dose with a half-life of approximately 4 hours, distinguishing it from immediate-release hydrocodone formulations.[1][3][4]

Other names
hydrocodone polistirex resin complex
02

Targets

DOR (Opioid Receptor Delta 1)CNR1 (Cannabinoid receptor 1)KOR (Kappa opioid receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on hydrocodone polistirex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocodone polistirex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call